• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 022024 Product 001 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N022024 001 5965584 Jun 19, 2016 Y U - 973
N022024 001 6099859 Mar 20, 2018 Y
N022024 001 6166042 Jun 19, 2016 U - 973
N022024 001 6166043 Jun 19, 2016 U - 973
N022024 001 6172090 Jun 19, 2016 U - 973
N022024 001 6495162 Mar 20, 2018 Y
N022024 001 6790459 Mar 17, 2021 U - 974
N022024 001 6866866 Mar 17, 2021 Y
N022024 001 7785627 Jul 31, 2026 Y
N022024 001 7919116 Mar 20, 2018 U - 973
N022024 001 7919116 Mar 20, 2018 U - 1120
N022024 001 7959946 Jul 31, 2026 Y
N022024 001 8470368 Sep 19, 2023 Y
N022024 001 8475841 Mar 20, 2018 U - 973
N022024 001 8668931 Sep 19, 2023 Y

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through August 2014
Patent and Generic Drug Product Data Last Updated October 01, 2014

-
-